Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > NSCLC

<< Previous

Bullboard Posts

Next >>

Comment by socksnblonds642on Oct 21, 2021 2:54pm

337 Views

Post# 34034015

RE:RE:RE:RE:NSCLC

Thanks, you have a great memory. I'd forgotten that. I have no concept of what the 10k less means to the body but it sounds promising. If this is a deciding factor in treatment selection, and it appears from that article that it is, then hopefully this is getting communicated to the patient via their doctor. They ultimately make the decision on which trial they use. But alas it may be the almighty dollar that dictated if this little tidbit gets to them.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand